Group One Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,815
| Closed | -$1.19M | – | 8162 |
|
|
2025
Q4 | $1.16M | Sell |
6,815
-1,988
| -23% | -$305K | ﹤0.01% | 2758 |
|
|
2025
Q3 | $1.16M | Buy |
8,803
+4,862
| +123% | +$583K | ﹤0.01% | 2875 |
|
|
2025
Q2 | $418K | Buy |
+3,941
| New | +$428K | ﹤0.01% | 3598 |
|
|
2024
Q1 | – | Sell |
-370
| Closed | -$45.3K | – | 7487 |
|
|
2023
Q4 | $45.5K | Buy |
+370
| New | +$46.2K | ﹤0.01% | 5137 |
|
|
2022
Q3 | – | Sell |
-661
| Closed | -$101K | – | 7858 |
|
|
2022
Q2 | $103K | Sell |
661
-1,142
| -63% | -$176K | ﹤0.01% | 4968 |
|
|
2022
Q1 | $281K | Sell |
1,803
-4,396
| -71% | -$638K | ﹤0.01% | 4439 |
|
|
2021
Q4 | $790K | Sell |
6,199
-11,712
| -65% | -$1.54M | ﹤0.01% | 3602 |
|
|
2021
Q3 | $2.33M | Sell |
17,911
-24,213
| -57% | -$3.66M | ﹤0.01% | 2494 |
|
|
2021
Q2 | $7.48M | Buy |
42,124
+7,260
| +21% | +$1.26M | 0.01% | 1326 |
|
|
2021
Q1 | $5.73M | Buy |
34,864
+12,476
| +56% | +$2.05M | 0.01% | 1396 |
|
|
2020
Q4 | $3.69M | Buy |
22,388
+21,217
| +1,812% | +$3.16M | 0.01% | 1525 |
|
|
2020
Q3 | $167K | Buy |
+1,171
| New | +$145K | ﹤0.01% | 3812 |
|
|
2020
Q1 | – | Sell |
-3,310
| Closed | -$428K | – | 5498 |
|
|
2019
Q4 | $494K | Buy |
3,310
+196
| +6% | +$26.7K | ﹤0.01% | 2441 |
|
|
2019
Q3 | $399K | Buy |
3,114
+1,971
| +172% | +$264K | ﹤0.01% | 2524 |
|
|
2019
Q2 | $163K | Buy |
+1,143
| New | +$154K | ﹤0.01% | 3005 |
|
|
2019
Q1 | – | Sell |
-3,058
| Closed | -$399K | – | 5070 |
|
|
2018
Q4 | $379K | Sell |
3,058
-3,938
| -56% | -$584K | ﹤0.01% | 2186 |
|
|
2018
Q3 | $1.18M | Buy |
+6,996
| New | +$1.2M | 0.01% | 1574 |
|
|
2018
Q1 | – | Sell |
-35,444
| Closed | -$5.2M | – | 5059 |
|
|
2017
Q4 | $4.77M | Buy |
+35,444
| New | +$4.92M | 0.03% | 661 |
|
|
2017
Q3 | – | Sell |
-14,553
| Closed | -$2.2M | – | 4984 |
|
|
2017
Q2 | $2.26M | Buy |
14,553
+14,009
| +2,575% | +$2.14M | 0.02% | 885 |
|
|
2017
Q1 | $79K | Buy |
+544
| New | +$70.9K | ﹤0.01% | 3120 |
|
|
2016
Q4 | – | Sell |
-20,945
| Closed | -$2.33M | – | 4614 |
|
|
2016
Q3 | $2.54M | Buy |
+20,945
| New | +$2.82M | 0.03% | 720 |
|
|
2016
Q2 | – | Sell |
-184
| Closed | -$27.1K | – | 4768 |
|
|
2016
Q1 | $24K | Buy |
+184
| New | +$22.9K | ﹤0.01% | 3652 |
|
|
2015
Q4 | – | Sell |
-14,384
| Closed | -$1.99M | – | 4899 |
|
|
2015
Q3 | $1.91M | Buy |
14,384
+13,454
| +1,447% | +$2.32M | 0.03% | 814 |
|
|
2015
Q2 | $164K | Buy |
930
+225
| +32% | +$40.4K | ﹤0.01% | 2679 |
|
|
2015
Q1 | $122K | Sell |
705
-55,838
| -99% | -$9.58M | ﹤0.01% | 2755 |
|
|
2014
Q4 | $9.26M | Sell |
56,543
-13,405
| -19% | -$2.22M | 0.14% | 134 |
|
|
2014
Q3 | $11.2M | Buy |
69,948
+8,979
| +15% | +$1.38M | 0.17% | 97 |
|
|
2014
Q2 | $8.96M | Sell |
60,969
-12,346
| -17% | -$1.71M | 0.14% | 139 |
|
|
2014
Q1 | $10.2M | Buy |
+73,315
| New | +$11M | 0.17% | 98 |
|
|
2013
Q4 | – | Sell |
-5,076
| Closed | -$525K | – | 5363 |
|
|
2013
Q3 | $467K | Buy |
5,076
+3,434
| +209% | +$277K | 0.01% | 1663 |
|
|
2013
Q2 | $113K | Buy |
+1,642
| New | +$100K | ﹤0.01% | 2704 |
|
Other funds holding JAZZ
VPM
VCM
EC
Group One Trading's JAZZ Position: Q1 2026 in Review
Group One Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 6,815 shares — an estimated $1.19M sold.
Group One Trading first reported a position in JAZZ in Q2 2013 and held it in 31 quarters. The position peaked at $11.2M in Q3 2014. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Group One Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 6,815 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.19M.
- Group One Trading first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 31 quarters.
- Group One Trading's Jazz Pharmaceuticals position peaked at $11.2M in Q3 2014.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.